GlucoTrack issues $2 million 5% convertible note to Alto Opportunity Master Fund in settlement deal

• GlucoTrack entered a settlement with Alto Opportunity Master Fund that includes a USD 2 million convertible promissory note.
• Note carries 5% interest, paid in four USD 500,000 quarterly principal installments from Nov. 30, 2026 to Aug. 31, 2027.
• Alto can convert principal into common stock at USD 2.98 per share, subject to a 9.99% ownership cap.
• Settlement also requires an initial USD 2 million cash payment, with up to USD 125,000 of Alto legal fees.
• Missed payments beyond a five-business-day cure period can trigger acceleration of amounts due under the settlement and note.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-041978), on September 09, 2026, and is solely responsible for the information contained therein.